Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
Canziani et al., Journal of Autoimmunity, doi:10.1016/j.jaut.2020.102511
https://c19early.org/canziani.html